Beta
29450

Levels of chemerin and asymmetric dimethylarginine (ADMA) in obese type 2 diabetic patients.

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

Biochemistry and molecular biology

Abstract

Diabetes Mellitus (D.M) has reached epidemic proportion and has become one of the most challenging health problems of the 21st century. Moreover, it is the 4th leading cause of death by disease globally, where every 10 seconds a person dies from diabetes-related causes. Obesity, insulin resistance, dyslipidemia and hypertension are associated with (T2DM) termed together as a metabolic syndrome. Mobilization of free fatty acids and secretion of certain inflammatory adipokines from adipose tissue promote insulin resistance in obese diabetics by interfere with insulin sensitivity, glucose and lipid metabolism. Chemerin, a specific adipokine, has an essential role in glucose and lipid metabolism. It plays a role in pathogenesis of obesity and T2DM also has important roles in energy metabolism, adipogenesis, and inflammation. Asymmetric dimethyl arginine (ADMA) consider a natural analogue of the essential amino acid arginine and a metabolic by-product obtained from processes of protein turnover of all human cells cytoplasm.

DOI

10.21608/rpbs.2019.5244.1012

Keywords

ADMA, Chemerin, Nitric oxide, Obesity, Type 2 diabetes mellitus

Authors

First Name

Ahmed

Last Name

Youssef

MiddleName

A

Affiliation

biochemistry department , faculty of pharmacy , egyptian russian university , cairo , egypt

Email

ahmedabdelghany217@yahoo.com

City

-

Orcid

-

First Name

Eman

Last Name

Mehanna

MiddleName

T

Affiliation

biochemistry,pharmacy, suez canal university, ismalia , egypt

Email

emanmehanna@yahoo.com

City

-

Orcid

-

First Name

Dina

Last Name

Abo-Elmatty

MiddleName

M.

Affiliation

biochemistry department ,Faculty of Pharmacy - Suez Canal University, ismalia, Egypt

Email

dinawahadan@yahoo.com

City

Ismailia

Orcid

0000-0002-6074-2714

Volume

3

Article Issue

1

Related Issue

5173

Issue Date

2019-03-01

Receive Date

2018-09-22

Publish Date

2019-03-01

Page Start

4

Page End

10

Print ISSN

2536-9857

Online ISSN

2535-2091

Link

https://rpbs.journals.ekb.eg/article_29450.html

Detail API

https://rpbs.journals.ekb.eg/service?article_code=29450

Order

2

Type

Mini-reviews

Type Code

534

Publication Type

Journal

Publication Title

Records of Pharmaceutical and Biomedical Sciences

Publication Link

https://rpbs.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023